Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Telomerase in urological malignancy.

C Orlando1, S Gelmini, C Selli

  • 1Clinical Biochemistry Unit Department of Clinical Physiopathology, University of Florence and Division of Urology, Department of Surgery, University of Pisa, Pisa, Italy.

The Journal of Urology
|July 18, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Purinoceptors in the Central Nervous System.

Drug development research·2024
Same author

Automatic lung segmentation in COVID-19 patients: Impact on quantitative computed tomography analysis.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2021
Same author

Corrigendum to "The pre-analytical phase of liquid biopsy" [New Biotechnol. 55, 25 March 2020, 19-29].

New biotechnology·2019
Same author

How standardization of the pre-analytical phase of both research and diagnostic biomaterials can increase reproducibility of biomedical research and diagnostics.

New biotechnology·2019
Same author

C-MYC, HIF-1α, ERG, TKT, and GSTP1: an Axis in Prostate Cancer?

Pathology oncology research : POR·2018
Same author

Alterations of store-operated calcium entry and cyclopiazonic acid-induced endothelium-derived relaxations in aging rat thoracic aorta.

Physiology international·2017
Same journal

On the Memoryless Property in Markov Models for NMIBC Cost-Effectiveness Analysis.

The Journal of urology·2026
Same journal

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same journal

Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

The Journal of urology·2026
Same journal

The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

The Journal of urology·2026
Same journal

Let's Shift the Focus from Death to Life after Fournier's Gangrene.

The Journal of urology·2026
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
See all related articles

Telomerase is active in most urological cancers, aiding tumor growth. Detecting telomerase in urine shows promise for diagnosing bladder cancer, but more research is needed for its clinical role in other urological malignancies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Telomerase is an enzyme crucial for maintaining telomere length, preventing cellular senescence.
  • Telomerase activity is repressed in most normal somatic cells but reactivated in over 90% of human cancers, contributing to cellular immortalization and carcinogenesis.
  • The distinct expression patterns of telomerase in cancer versus normal tissues make it a significant target for cancer research and therapy.

Purpose of the Study:

  • To review current data on telomerase detection in urological malignancies.
  • To explore the potential of telomerase inhibition as an anti-cancer therapeutic strategy.
  • To assess the diagnostic and clinical relevance of telomerase in bladder, prostate, and renal cancers.

Main Methods:

Related Experiment Videos

  • Comprehensive literature review of recent publications.
  • MEDLINE database search for relevant studies.
  • Analysis of telomerase detection methods and clinical findings in urological cancers.

    • Main Results:

    • Telomerase is frequently detected in bladder (90%), prostate (80%), and renal (69%) carcinomas.
    • Telomerase activity is also found in some normal tissues adjacent to tumors.
    • Telomerase shows diagnostic potential in bladder and prostate cancers, particularly via detection in exfoliated cells in urine.

    Conclusions:

    • Further large-scale studies are necessary to establish the definitive clinical role of telomerase in urological tumors.
    • Improving quantitative methods for assessing telomerase expression is essential for clarifying its clinical significance.
    • Telomerase detection in urine is a promising non-invasive tool for bladder cancer diagnosis and management.